PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA
PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA
View ArticleBiogen & Ionis: SPINRAZA Meets Primary Endpoint In Phase 3 Study - Quick Facts
Biogen & Ionis: SPINRAZA Meets Primary Endpoint In Phase 3 Study - Quick Facts
View ArticleIonis Pharmaceuticals (IONS) & Biogen (BIIB) Are Up On Phase 3 Study Results
Ionis Pharmaceuticals (IONS) & Biogen (BIIB) Are Up On Phase 3 Study Results
View ArticleBiogen, Ionis Shares Rise After Positive Study Results
Biogen, Ionis Shares Rise After Positive Study Results
View ArticleBiogen, Ionis Shares Up After Positive Study Results
Biogen, Ionis Shares Up After Positive Study Results
View ArticleMDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS
MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS
View ArticleStocks Showing Strong Upward Move In Mid-Day Trading - U.S. Commentary
Stocks Showing Strong Upward Move In Mid-Day Trading - U.S. Commentary
View ArticleWhat''s In The Offing For These Biotech Stocks?
What''s In The Offing For These Biotech Stocks?
View ArticleIONS Scripts History, PTLA Gets FDA Date, Strongbridge Slumps, NEOT On Watch
IONS Scripts History, PTLA Gets FDA Date, Strongbridge Slumps, NEOT On Watch
View ArticleIonis Posting Strong Gain After FDA Approves Spinraza
Ionis Posting Strong Gain After FDA Approves Spinraza
View ArticleBiogen, Ionis Get FDA Approval For SMA Drug
Biogen, Ionis Get FDA Approval For SMA Drug
View ArticleIonis Pharma Collaborates With Novartis On Cardiovascular Treatment
Ionis Pharma Collaborates With Novartis On Cardiovascular Treatment
View ArticleIonis Pharmaceuticals (IONS) Is Losing Ground After Downgrade
Ionis Pharmaceuticals (IONS) Is Losing Ground After Downgrade
View ArticleIonis Pharmaceuticals Posting Steep Loss In Afternoon Trading
Ionis Pharmaceuticals Posting Steep Loss In Afternoon Trading
View ArticleStocks Close Mostly Higher Amid Increase In Oil Prices - U.S. Commentary
Stocks Close Mostly Higher Amid Increase In Oil Prices - U.S. Commentary
View ArticleAKBA Abuzz, ANTH On Track For RESULT, IMUC Faces Cash Crunch, IONS Falls
AKBA Abuzz, ANTH On Track For RESULT, IMUC Faces Cash Crunch, IONS Falls
View ArticleGainers & Losers Of July 25: FLKS, MYOK, SYRS, PCRX, RETA...
Gainers & Losers Of July 25: FLKS, MYOK, SYRS, PCRX, RETA...
View ArticleIonis Retains All Rights To Inotersen, IONIS-FB-L Rx; GSK Declines Its Options
Ionis Retains All Rights To Inotersen, IONIS-FB-L Rx; GSK Declines Its Options
View ArticleGainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA...
Gainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA...
View Article